adenosine diphosphate has been researched along with Multiple Myeloma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berndt, MC; Hasegawa, Y; Kaneko, S; Kojima, H; Nagasawa, T; Shigeta, O; Shinagawa, A; Suzukawa, K | 1 |
| Berg, A; Le Blanc, K; Palmblad, J; Samuelsson, J | 1 |
| Attardi, G; Greco, M; Papa, S; Villani, G | 1 |
| Ohshima, M; Terada, H | 1 |
| Avramova, D; Dobreva, A; Ignatova, E; Lisichkov, T; Meshkov, T | 1 |
| Glueck, CJ; Glueck, HI; MacKenzie, MR | 1 |
6 other study(ies) available for adenosine diphosphate and Multiple Myeloma
| Article | Year |
|---|---|
Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.
Topics: Adenosine Diphosphate; Adrenergic Agonists; Antibodies, Monoclonal; Anticoagulants; Blood Coagulation; Buffers; Cell Adhesion; Collagen; Crotalid Venoms; Dimerization; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Epinephrine; Female; Formaldehyde; Hematuria; Hemostasis; Humans; Immunoblotting; Immunoglobulin D; Isoelectric Point; Middle Aged; Multiple Myeloma; Partial Thromboplastin Time; Platelet Adhesiveness; Platelet Aggregation; Protein Binding; Protein Structure, Tertiary; Prothrombin Time; Thrombin; Time Factors; von Willebrand Diseases; von Willebrand Factor | 2005 |
Stimulus-specific defect in platelet aggregation in polycythemia vera.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Blood Platelets; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luminescent Measurements; Middle Aged; Multiple Myeloma; Platelet Activating Factor; Platelet Aggregation; Polycythemia Vera; Tetradecanoylphorbol Acetate | 1994 |
Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types.
Topics: Adenosine Diphosphate; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line; Cell Membrane Permeability; Digitonin; Electron Transport Complex IV; Glutamic Acid; Humans; Kinetics; Liver Neoplasms; Lung Neoplasms; Malates; Mitochondria; Multiple Myeloma; Neuroblastoma; Osteosarcoma; Oxygen Consumption; Potassium Cyanide; Tetramethylphenylenediamine; Tumor Cells, Cultured | 1998 |
[ATP and ADP of platelets in chronic myeloproliferative disorders and multiple myeloma].
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Blood Platelets; Chronic Disease; Humans; Middle Aged; Multiple Myeloma; Myeloproliferative Disorders; Platelet Aggregation | 1989 |
[Thrombocyte functions in malignant blood diseases].
Topics: Acute Disease; Adenosine Diphosphate; Blood Platelets; Epinephrine; Hemostasis; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Multiple Myeloma; Platelet Aggregation; Platelet Count | 1987 |
Crystalline IgG protein in multiple myeloma: identification effects on coagulation and on lipoprotein metabolism.
Topics: Adenosine Diphosphate; Adipose Tissue; Antibodies; Blood Coagulation; Blood Coagulation Factors; Crystallization; Drug Resistance; Esterases; Glycerides; Heparin; Humans; Immunoglobulin G; Immunoglobulins; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Platelet Adhesiveness; Protein Binding; Thrombin; Tosyl Compounds; Tritium | 1972 |